KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to 0.52.

  • Aurinia Pharmaceuticals' Asset Utilization Ratio rose 2563.58% to 0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52, marking a year-over-year increase of 2563.58%. This contributed to the annual value of 0.43 for FY2024, which is 2424.05% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Asset Utilization Ratio is 0.52, which was up 2563.58% from 0.52 recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.52 in Q2 2025 and a low of 0.0 during Q1 2021
  • For the 5-year period, Aurinia Pharmaceuticals' Asset Utilization Ratio averaged around 0.28, with its median value being 0.32 (2023).
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Asset Utilization Ratio skyrocketed by 1745718.08% in 2021, and later skyrocketed by 825.39% in 2023.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.1 in 2021, then surged by 176.82% to 0.28 in 2022, then grew by 13.86% to 0.32 in 2023, then soared by 34.34% to 0.43 in 2024, then rose by 20.72% to 0.52 in 2025.
  • Its Asset Utilization Ratio stands at 0.52 for Q3 2025, versus 0.52 for Q2 2025 and 0.47 for Q1 2025.